Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 7:3:818732.
doi: 10.3389/falgy.2022.818732. eCollection 2022.

The Effector Function of Allergens

Affiliations
Review

The Effector Function of Allergens

Stéphane Hazebrouck et al. Front Allergy. .

Abstract

Allergens are antigens that generate an IgE response (sensitization) in susceptible individuals. The allergenicity of an allergen can be thought of in terms of its ability to sensitize as well as its ability to cross-link IgE/IgE receptor complexes on mast cells and basophils leading to release of preformed and newly formed mediators (effector activity). The identity of the allergens responsible for sensitization may be different from those that elicit an allergic response. Effector activity is determined by (1) the amount of specific IgE (sIgE) and in some circumstances the ratio of sIgE to total IgE, (2) the number of high affinity receptors for IgE (FcεR1) on the cell surface, (3) the affinity of binding of sIgE for its epitope and, in a polyclonal response, the collective avidity, (4) the number and spatial relationships of IgE binding epitopes on the allergen and (5) the presence of IgG that can bind to allergen and either block binding of sIgE and/or activate low affinity IgG receptors that activate intracellular inhibitory pathways. This review will discuss these important immunologic and physical properties that contribute to the effector activity of allergens.

Keywords: IgE; allergens; cross-linking; degranulation; effector function; epitope; fcepsilonR1; mast cells.

PubMed Disclaimer

Conflict of interest statement

SCD has received grant support from the National Institutes of Health. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Pomes A, Davies JM, Gadermaier G, Hilger C, Holzhauser T, Lidholm J, et al. . WHO/IUIS allergen nomenclature: providing a common language. Mol Immunol. (2018) 100:3–13. 10.1016/j.molimm.2018.03.003 - DOI - PMC - PubMed
    1. Aalberse RC. Structural biology of allergens. J Allergy Clin Immunol. (2000) 106:228–38. 10.1067/mai.2000.108434 - DOI - PubMed
    1. Aalberse RC. Structural features of allergenic molecules. Chem Immunol Allergy. (2006) 91:134–46. 10.1159/000090277 - DOI - PubMed
    1. Traidl-Hoffmann C, Jakob T, Behrendt H. Determinants of allergenicity. J Allergy Clin Immunol. (2009) 123:558–66. 10.1016/j.jaci.2008.12.003 - DOI - PubMed
    1. Deifl S, Bohle B. Factors influencing the allergenicity and adjuvanticity of allergens. Immunotherapy. (2011) 3:881–93. 10.2217/imt.11.69 - DOI - PubMed